Additionally, post-mortem human tauopathy brains show a high degree of heterogeneity of tau pathology (reviewed in [17]), which is poorly recapitulated in transgenic animals—both in terms of the structure of tau aggregates and the affected cell types. This evidence concerns the gene MAPT and tauopathy.